FDA Inspection 675546 — Vitalant

Vitalant — FEI 3071345

The FDA completed an inspection of Vitalant on July 21, 2010 in Spokane, WA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 21, 2010
Fiscal Year
2010
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Spokane, WA (United States)

Citations

IDCFRDescription
21221 CFR 640.3(b)(3)Qualifications of donor - hemoglobin
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
9821 CFR 606.100(c)Thorough investigations